Foundation News

Stay up-to-date with the most current news and information about the Crohn's & Colitis Foundation, as well as Crohn's disease and ulcerative colitis.

Filter results

Crohn’s & Colitis Foundation announces Sharon Lungrin as new member of senior leadership team

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today

July 18, 2022

Pomegranate extract dietary supplement lowers Inflammation and reduces disease severity in a pre-clinical model of colitis

NEW YORK, NY – Dietary supplementation of pomegranate extract decreased disease severity and lowered inflammation in mice with colitis, according to a new study published in Molecular Nutrition and Food Research and

February 25, 2022

First-of-its-kind technology provides individualized, actionable insights on dose and interval for infliximab

Prometheus Laboratories recently announced the launch of PredictrPK IFX, which uses a machine learning algorithm to combine patient weight, current dose and interval, measured serum IFX, measured antibodies-to-infliximab and albumin levels to predict optimal, individualized infliximab dosing.

February 23, 2022

We Can’t Wait App featured in Fast Company

CEO Michael Osso recently spoke with Fast Company about how the We Can’t Wait app is connecting users to over 45,000 public restrooms across the country.

February 15, 2022

We Can’t Wait: New app helps inflammatory bowel disease patients find available restrooms nearby

NEW YORK, NY — The Crohn’s & Colitis Foundation, the leading non-profit dedicated to finding cures for inflammatory bowel disease (IBD) and improving patient quality of life, today launched the We Can’t Wait app, which provides an interactive map that allows users to find a restroom near them

February 8, 2022

11 Health & Technologies receives funding from Crohn’s & Colitis Foundation IBD Ventures to further develop world’s first digital ostomy wearable, the Remote Output Monitor

ORANGE COUNTY, CA – 11 Health & Technologies Inc., a medical technology company with a proven technology to reduce complications in ostomy patients, announced today that it has received funding from the Crohn’s & Colitis Foundation’s

January 10, 2022

Researchers use stem cell technology to replicate diseased human guts and understand fibrosis in inflammatory bowel disease

New York, NY – The Crohn’s & Colitis Foundation today announced a breakthrough in the study of intestinal fibrosis in inflammatory bowel disease (IBD) patients, published in IBD Journal.

December 17, 2021

Researchers receive funding award to compare targeted treatment approaches to improve long-term outcomes in patients with IBD

NEW YORK, NY – Crohn’s disease and ulcerative colitis, also known as inflammatory bowel disease (IBD), affect millions of Americans and can significantly impair patient quality of life.

October 14, 2021

Crohn’s & Colitis Foundation receives $3 million donation to advance precision medicine in IBD

New York, NY -- The Crohn’s & Colitis Foundation (the Foundation) announced today that it received a $3 million donation from Jonathan D. Rose, MD, PhD, to support two major Foundation research programs: IBD-SIRQC, a national, prospective surgical cohort, and the Jonathan D.

September 14, 2021

Crohn’s & Colitis Foundation Recognizes 16 Healthcare Providers with Uniting to Care & Cure Awards

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that it is presenting its Uniting to Care & Cure Awards to 16 healthcare providers from across the country in recognition of their work to help find cures for inflammatory bowel disease (IBD) and improve the quality of life o

June 11, 2021